Echocardiographic findings in patients with COVID-19 pneumonia.
Mahmoud-Elsayed, Hani M Moody, William E Bradlow, William M Khan-Kheil, Ayisha M Senior, Jonathan Hudsmith, Lucy E Steeds, Richard P
Mahmoud-Elsayed, Hani M
Moody, William E
Bradlow, William M
Khan-Kheil, Ayisha M
Senior, Jonathan
Hudsmith, Lucy E
Steeds, Richard P
Abstract
The aim of this study was to characterize the echocardiographic phenotype of patients with COVID-19 pneumonia and its relation to biomarkers. Seventy-four patients (59 ± 13 years old, 78% male) admitted with COVID-19 were included after referral for transthoracic echocardiography as part of routine care. A level 1 British Society of Echocardiography transthoracic echocardiography was used to assess chamber size and function, valvular disease, and likelihood of pulmonary hypertension. The chief abnormalities were right ventricle (RV) dilatation (41%) and RV dysfunction (27%). RV impairment was associated with increased D-dimer and C-reactive protein levels. In contrast, left ventricular function was hyperdynamic or normal in most (89%) patients.
MIDER Authors
Affiliations
Citations
Altmetric:
Date
2020-05-28
Type
Article
Other
Other
Subject
Collections
Citation
Mahmoud-Elsayed HM, Moody WE, Bradlow WM, Khan-Kheil AM, Senior J, Hudsmith LE, Steeds RP. Echocardiographic Findings in Patients With COVID-19 Pneumonia. Can J Cardiol. 2020 Aug;36(8):1203-1207. doi: 10.1016/j.cjca.2020.05.030. Epub 2020 May 28